More significantly, DCTPP1 expression was obviously related to higher tumor stage and grade (Table 1) and exhibited strong correlation with lower overall survival probability and a poor prognosis in breast cancer patients (Figure 1d).This not only provided clinical evidence for DCTPP1 to be engaged in cancer progression, but also might make DCTPP1 become an additional prognosis biomarker in breast cancer. This evidence concerns the gene DCTPP1 and neoplasm.